Context Therapeutics

Manufacturing · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

$100 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Context Therapeutics

Context Therapeutics is focused on advancing the treatment of female cancers through innovative T cell engaging bispecific antibody therapies. Their clinical-stage pipeline includes CTIM-76, CT-95, and CT-202, which are designed to leverage the immune system for targeted cancer eradication. The company aims to transform cancer care and improve outcomes for patients with challenging solid tumors. Context Therapeutics is dedicated to progressing their therapies from laboratory research to clinical application.Explore more
Context Therapeutics's Social MediaPopular SearchesContext Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

Context Therapeutics Org Chart

PhoneEmail
BH
United States flag for contact location.

Vice President, Clinical Development

PhoneEmail
MS
United States flag for contact location.

Vice President, Clinical Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
EZ
United States flag for contact location.

Senior Director, Quality

PhoneEmail
JW
United States flag for contact location.

Senior Director, Program Management

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Context Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Context Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Context Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Context Therapeutics.

Top Manufacturing Companies

Frequently Asked Questions Regarding Context Therapeutics

What is Context Therapeutics's official website?
Context Therapeutics's official website is www.contexttherapeutics.info
What is Context Therapeutics's Revenue?
Context Therapeutics's revenue is $100 Million
What is Context Therapeutics's SIC code?
Context Therapeutics's SIC: 28,283
What is Context Therapeutics's NAICS code?
Context Therapeutics's NAICS: 32,325
How many employees does Context Therapeutics have?
Context Therapeutics has 1-10 employees
What industry does Context Therapeutics belong to?
Context Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What does Context Therapeutics do?

Context Therapeutics is focused on advancing the treatment of female cancers through innovative T cell engaging bispecific antibody therapies. Their clinical-stage pipeline includes CTIM-76, CT-95, and CT-202, which are designed to leverage the immune system for targeted cancer eradication. The company aims to transform cancer care and improve outc... omes for patients with challenging solid tumors. Context Therapeutics is dedicated to progressing their therapies from laboratory research to clinical application.Read More

What are Context Therapeutics social media links?
Context Therapeutics Linkedin page Context Therapeutics Twitter page
Is Context Therapeutics a public company?
Context Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Context Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.